CCR2 and neoplasm: Consistently, CSF-1– CSF-1 receptor (CSF-1R) axis blockade or macrophage recruitment blockade via C-C chemokine receptor type 2 (CCR2)-inhibition could restore immune response against tumor in cancer models (69, 70).